Maya Sophie de Wilde

Dr. Maya Sophie de Wilde


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2026 in Medicine
Verified
Journal Article
Open access
CLChunhuai Liao
Chunhuai Liao
JLJian Lu
Jian Lu
LRLuz Angela Torres-de la Roche
Luz Angela Torres-de la Roche
Rudy Leon De WildeRudy Leon De Wilde
Rudy Leon De Wilde
TLTao Liu
Tao Liu
MWMaya Sophie de Wilde
Maya Sophie de Wilde
This study compares technetium-99m stannous phytate (99mTc-PHY) plus methylene blue versus technetium-99m sulfur colloid (99mTc-SC) plus methylene blue for sentinel lymph node (SLN) imaging in early-stage breast cancer (BC). We retrospectively reviewed early-stage BC patients treated from 2019 to 2024. All underwent sentinel lymph node biopsy using either 99mTc-PHY with methylene blue or 99mTc-SC with methylene blue as tracers. A Neoprobe 2000r detector was used to locate nodes. A total of 1151 patients were enrolled in the study, of whom 669 received 99mTc-SC and 482 received 99mTc-PHY (mean age 52 years). The SLN detection rates were 98.8% and 97.3%, respectively ( P = .06). The positive SLN rates for metastasis (14.8% vs 11.7%; P = .13) and the median SLN counts were comparable (4 vs 3; P = .27). In multivariable analysis, higher tumor stage (T1–T2) but not histological type (ductal or lobular) was independently associated with increased SLN count in both groups (T1: incidence rate ratios = 1.318; T2: incidence rate ratios = 1.686; both P < .001). The rate of axillary lymph node dissection was found to be significantly lower in the 99mTc-SC group (26.5% vs 43.6%; P = .03). However, the reasons for this difference were not identified. No perioperative adverse events were reported. The present findings provide support for the use of 99mTc-PHY as a feasible tracer in the context of SLN detection in BC patients, thus exhibiting no statistically significant difference in detection rates compared to 99mTc-SC.

5 September 2026 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
VTVlad Iustin Tica
Vlad Iustin Tica
LSLiliana Steriu
Liliana Steriu
DBDragos Brezeanu
Dragos Brezeanu
ATANDREI ADRIAN TICA
ANDREI ADRIAN TICA
ABAna-Maria Brezeanu
Ana-Maria Brezeanu
MWMaya Sophie de Wilde
Maya Sophie de Wilde
Background: Quality assurance (QA) is a cornerstone of safe and effective postgraduate training in gynecological laparoscopic surgery, where clinical outcomes depend on procedural complexity, equipment sophistication, and the coordinated competence of an entire surgical team. This article is a narrative review of the conceptual, professional, and regulatory foundations of QA in healthcare education, complemented by a structured synthesis of the collective teaching and clinical experience of the author group. It is not an empirical study, and the sections that follow present a conceptual mapping supported by expert perspective rather than original outcome data. Methods: Sources were identified through targeted searches of PubMed/MEDLINE and Google Scholar, supplemented by hand-searching of policy and curriculum documents issued by professional bodies and by backward citation tracking, without date restriction. Approximately 480 records were screened at title and abstract level, 112 were assessed as full text, and 41 sources were retained against predefined inclusion and exclusion criteria, with five further sources added during peer review. In a second and separate step, the ten co-authors, who hold teaching and supervisory roles in gynecological laparoscopy across academic centers in Romania and Germany, each completed the same six-item written prompt on training provision, trainer development, trainee assessment, and institutional QA practice; responses were coded thematically by two authors independently and consolidated into explicit points of convergence and divergence. Results: We describe how QA principles, originally articulated in general quality-management and health-promotion literature, have been adapted by professional and regulatory bodies, including the European Board and College of Obstetrics and Gynecology (EBCOG), European Society for Gynecological Endoscopy (ESGE), American Society for Gastrointestinal Endoscopy (ASGE), and the UK General Medical Council, into concrete standards for training providers, trainers, and trainees. We outline the structures used to monitor and audit training quality, including Kirkpatrick’s four-level evaluation model and periodic institutional review cycles, alongside documentation and certification pathways such as the Gynecological Endoscopic Surgical Education and Assessment (GESEA) program, with governance and financing as cross-cutting determinants of sustainability. The author synthesis converged on a consistent gap between documented standards and their routine enforcement and diverged on whether external review and formal certification should become mandatory. Conclusions: The conceptual architecture of QA in gynecological laparoscopy is coherent and broadly fit for purpose, but we identified no study linking the implementation of a specific QA standard to measurable gains in trainee competency or patient outcomes in this field. Proposals for harmonized, outcome-oriented, and where appropriate, mandatory external review should therefore be read as reasoned positions awaiting prospective evaluation rather than as evidence-based recommendations; generating that evidence, with the trainee’s own perspective collected rather than inferred, is the principal task for future research.

24 February 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MBMaria Mercedes BINDA
Maria Mercedes BINDA
MWMaya Sophie de Wilde
Maya Sophie de Wilde
Rudy Leon De WildeRudy Leon De Wilde
Rudy Leon De Wilde
Philippe R KoninckxPhilippe R Koninckx
Philippe R Koninckx
Objectives: The peritoneal cavity is a cavity outside the bloodstream, with a specific hormonal, immunological and microbiological micro-environment distinct from plasma. The mesothelial cells lining the peritoneal cavity react within seconds to minor trauma, such as blood, with retraction, acute inflammation and later inflammation. This mesothelial cell retraction exposes the basal membrane, facilitating the implantation of tumour cells. Acute inflammation enhances adhesion formation after surgery and causes pain. The aim of the review was to check the hypothesis that retrograde menstruation, occurring in most women, is sufficient to cause some peritoneal irritation. Design: A systematic review of menstrual C-reactive protein (CRP) concentrations, a non-specific marker of peritoneal inflammation (PROSPERO ID 536306). Results: All articles (n = 8) showed a variable increase in CRP concentrations during the menstrual and early follicular phase of 80 ± 36%. Conclusions: CRP concentrations are slightly increased during menstruation and the early follicular phase. This increase is likely due to retrograde menstruation, causing mesothelial cell retraction and acute pelvic inflammation. It seems logical that mesothelial cell retraction facilitates endometrial cell implantation and accounts for the anatomical distribution of endometriosis lesions. Acute pelvic inflammation may enhance postoperative adhesion formation.

30 September 2025 in Human Reproduction Open
Verified
Journal Article
Open access
PDF file
Harald KrentelHarald Krentel
Harald Krentel
Rudy Leon De WildeRudy Leon De Wilde
Rudy Leon De Wilde
MWMaya Sophie de Wilde
Maya Sophie de Wilde
The scientific gap - Facts, Views and Vision in ObGyn

19 March 2026 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Open access
PDF file
LRLuz Angela Torres-de la Roche
Luz Angela Torres-de la Roche
ASAlina Jara Schulte
Alina Jara Schulte
Rudy Leon De WildeRudy Leon De Wilde
Rudy Leon De Wilde
RDRajesh Devassy
Rajesh Devassy
GTGarri Tchartchian
Garri Tchartchian
MWMaya Sophie de Wilde
Maya Sophie de Wilde
Introduction: Hysterectomy is a frequently employed treatment modality in gynaecological diseases. In the context of various approaches to vaginal hysterectomy, laparoscopically-assisted vaginal hysterectomy (LAVH) could eventually improve the safety in cases where patients without genital prolapse present with preoperative peritoneal adhesions. The present analysis examined intraoperative and immediate postoperative adhesions-related outcomes. Methods: Monocentric, comparative, retrospective study of a single cohort of women without genital prolapse who underwent LAVH for benign gynaecological conditions between January 2010 and December 2019. Patients without peritoneal adhesions were compared with patients with adhesions, as diagnosed at the beginning of the procedure. Mann–Whitney-U test was used for the comparative analysis. Results: Among 1,638 patients, 562 patients (34.3%) had preoperative adhesions. Main indications were for myoma (71%) and adenomyosis (14.9%). The mean operation time in the adhesion group was significantly longer than in the no-adhesion group (106 ± 44 min vs. 90 ± 35 min; p < 0.001). Adhesiolysis was required in 88% within the adhesion group (n = 495). No significant differences were observed regarding mean estimated intraoperative blood loss (87 ± 100 ml vs. 90 ± 95 ml; p = 0, 418), uterine weight (220 ± 227 g vs. 230 ± 203 g; p = 0, 38), or morcellation (52% vs. 55.8%; p = 0, 142). Most patients in both groups did not experience complications (95% vs. 97.2%). Laparoconversion due to technical difficulties in performing the endocopic surgery or due to the presence of adhesions was rarely needed (1.6% vs. 0.6%). The intraoperative complication rate was low but significantly different in both groups (2% vs. 0.7%; p = 0.02), including bowel injuries (n = 6 vs. n = 3) and urinary bladder injuries (n = 4 vs. n = 5). %), which were diagnosed immediately and treated successfully. The postoperative complication rate was similar in both groups (3.4% vs. 2.1%; p = 0.138), mainly urinary tract infection. All adverse events were treated successfully; second laparoscopic surgery was conducted in five patients with adhesions and in nine patients without adhesions for haematoma removal. Conclusion: LAVH could be considered a safe and feasible surgical approach for women without genital prolapse who have preoperative peritoneal adhesions and require vaginal hysterectomy for benign gynaecological conditions. This approach facilitates the localisation and treatment of adhesions at the commencement of surgery, as well as the control of possible injuries that may arise during the procedure, and is associated with a low complication rate.

15 April 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MWMaya Sophie de Wilde
Maya Sophie de Wilde
KSKaylen Silverberg
Kaylen Silverberg
TAThamer Alahmad
Thamer Alahmad
RDRajesh Devassy
Rajesh Devassy
Rudy Leon De WildeRudy Leon De Wilde
Rudy Leon De Wilde
LRLuz Angela Torres-de la Roche
Luz Angela Torres-de la Roche
Background/Objectives: The objective of this study was to evaluate, for the first time, the effectiveness and safety of 4% icodextrin solution by detecting the incidence of adhesion-related morbidities (adhesion-related hospital readmissions, including reoperations) when used as an adhesion prophylactic agent during laparoscopic gynecologic surgery. Methods: The study was a single-arm, two-center, retrospective study. The incidence of hospital readmissions that were directly or possibly related to adhesions following the use of 4% icodextrin in laparoscopic gynecologic surgery, 2 years from the date of index surgery, was assessed either via chart review alone or, when found necessary, in combination with patient-completed questionnaires. Patient safety was evaluated through reported adverse events. The relationship between clinical events and the use of 4% icodextrin was assessed by investigators based on patient-level data. Results: After 149 patients were screened, the study finally included 123 patients; 4 (3.3%; 95% CI: 0.89%, 8.12%) had at least one reoperation or readmission that was directly or possibly related to adhesion within 2 years of index surgery. In the supplemental analysis (67 patients using chart and questionnaire data), this incidence rate was 10.4% (95% CI: 4.30%, 20.35%). No adverse events related to the use of 4% icodextrin were reported. Conclusions: This is the first study ever evaluating hospital readmission/reoperation rates after application of a specific adhesion prophylactic agent. The results indicate that 4% icodextrin is safe and effective when used as an intraperitoneal instillate for reduction in adhesions in gynecological laparoscopic procedures. It has a lower readmission and reoperation rate compared to meta-analysis data in the international literature.